鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/10/25 | 4,090 | 4,090 | 3,860 | 3,870 | -220 | -5.4% | 94,800 |
2024/10/24 | 4,110 | 4,145 | 3,965 | 4,090 | -60 | -1.4% | 127,700 |
2024/10/23 | 3,920 | 4,180 | 3,920 | 4,150 | +220 | +5.6% | 139,000 |
2024/10/22 | 3,920 | 3,940 | 3,915 | 3,930 | -10 | -0.3% | 14,600 |
2024/10/21 | 3,915 | 3,945 | 3,910 | 3,940 | +25 | +0.6% | 6,900 |
2024/10/18 | 3,920 | 3,950 | 3,915 | 3,915 | ±0 | ±0% | 11,300 |
2024/10/17 | 3,905 | 3,935 | 3,905 | 3,915 | +10 | +0.3% | 8,300 |
2024/10/16 | 3,860 | 3,935 | 3,860 | 3,905 | +10 | +0.3% | 11,900 |
2024/10/15 | 3,940 | 3,940 | 3,885 | 3,895 | ±0 | ±0% | 19,000 |
2024/10/11 | 3,940 | 3,940 | 3,870 | 3,895 | -50 | -1.3% | 13,500 |
2024/10/10 | 3,925 | 3,945 | 3,890 | 3,945 | +20 | +0.5% | 8,700 |
2024/10/09 | 3,890 | 3,930 | 3,890 | 3,925 | +35 | +0.9% | 8,700 |
2024/10/08 | 3,905 | 3,950 | 3,885 | 3,890 | -45 | -1.1% | 18,800 |
2024/10/07 | 3,940 | 3,960 | 3,910 | 3,935 | +10 | +0.3% | 15,000 |
2024/10/04 | 3,960 | 3,965 | 3,925 | 3,925 | -5 | -0.1% | 8,700 |
2024/10/03 | 3,930 | 3,960 | 3,885 | 3,930 | +70 | +1.8% | 23,500 |
2024/10/02 | 3,880 | 3,920 | 3,845 | 3,860 | -40 | -1% | 39,600 |
2024/10/01 | 3,915 | 3,915 | 3,885 | 3,900 | +25 | +0.6% | 13,300 |
2024/09/30 | 3,870 | 3,900 | 3,845 | 3,875 | -25 | -0.6% | 24,300 |
2024/09/27 | 3,905 | 3,950 | 3,890 | 3,900 | -15 | -0.4% | 25,400 |
2024/09/26 | 3,865 | 3,935 | 3,850 | 3,915 | +65 | +1.7% | 39,100 |
2024/09/25 | 3,870 | 3,890 | 3,825 | 3,850 | +15 | +0.4% | 40,900 |
2024/09/24 | 3,830 | 3,855 | 3,815 | 3,835 | +20 | +0.5% | 17,400 |
2024/09/20 | 3,825 | 3,845 | 3,790 | 3,815 | +35 | +0.9% | 24,800 |
2024/09/19 | 3,750 | 3,805 | 3,730 | 3,780 | +30 | +0.8% | 16,500 |
2024/09/18 | 3,755 | 3,765 | 3,715 | 3,750 | +25 | +0.7% | 15,600 |
2024/09/17 | 3,770 | 3,770 | 3,695 | 3,725 | -25 | -0.7% | 30,400 |
2024/09/13 | 3,740 | 3,775 | 3,700 | 3,750 | +10 | +0.3% | 28,500 |
2024/09/12 | 3,565 | 3,770 | 3,565 | 3,740 | +185 | +5.2% | 58,300 |
2024/09/11 | 3,605 | 3,605 | 3,540 | 3,555 | -65 | -1.8% | 34,500 |
2024/09/10 | 3,700 | 3,700 | 3,605 | 3,620 | -80 | -2.2% | 21,000 |
2024/09/09 | 3,595 | 3,710 | 3,595 | 3,700 | +65 | +1.8% | 26,000 |
2024/09/06 | 3,645 | 3,645 | 3,620 | 3,635 | -10 | -0.3% | 13,400 |
2024/09/05 | 3,630 | 3,695 | 3,630 | 3,645 | -5 | -0.1% | 18,000 |
2024/09/04 | 3,655 | 3,690 | 3,615 | 3,650 | -65 | -1.7% | 19,800 |
2024/09/03 | 3,645 | 3,715 | 3,645 | 3,715 | +70 | +1.9% | 28,400 |
2024/09/02 | 3,690 | 3,715 | 3,605 | 3,645 | -45 | -1.2% | 19,700 |
2024/08/30 | 3,720 | 3,735 | 3,660 | 3,690 | ±0 | ±0% | 43,800 |
2024/08/29 | 3,630 | 3,705 | 3,630 | 3,690 | +75 | +2.1% | 23,300 |
2024/08/28 | 3,545 | 3,645 | 3,545 | 3,615 | +65 | +1.8% | 24,600 |
2024/08/27 | 3,495 | 3,555 | 3,475 | 3,550 | +70 | +2% | 19,500 |
2024/08/26 | 3,450 | 3,480 | 3,450 | 3,480 | +40 | +1.2% | 9,600 |
2024/08/23 | 3,455 | 3,465 | 3,435 | 3,440 | -15 | -0.4% | 17,300 |
2024/08/22 | 3,445 | 3,455 | 3,415 | 3,455 | +30 | +0.9% | 9,200 |
2024/08/21 | 3,455 | 3,470 | 3,405 | 3,425 | -55 | -1.6% | 14,800 |
2024/08/20 | 3,465 | 3,480 | 3,420 | 3,480 | +60 | +1.8% | 6,200 |
2024/08/19 | 3,445 | 3,485 | 3,420 | 3,420 | -70 | -2% | 13,900 |
2024/08/16 | 3,485 | 3,490 | 3,445 | 3,490 | +35 | +1% | 23,900 |
2024/08/15 | 3,470 | 3,475 | 3,430 | 3,455 | -15 | -0.4% | 22,900 |
2024/08/14 | 3,500 | 3,500 | 3,445 | 3,470 | -25 | -0.7% | 12,600 |
201~
250
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
キッセイ薬 | 429,000円 | +3.6% | - | 2.80% | 14.46倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ペプチド | 151,600円 | +5.0% | +1.5% | 0.00% | 12.97倍 | 3.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム